Первая клетка. И чего стоит борьба с раком до последнего

At the Forefront of Cancer Genetics, Bert Vogelstein, MD, Calls for Focus on Early Detection and Prevention. ASCO Post, June 3, 2017. https://ascopost.com/issues/june-3–2017-narratives-special-issue/at-the-forefront-of-cancer-genetics-bert-vogelstein-md-calls-for-focus-on-early-detection-and-prevention

DeVita V. T., Jr., DeVita-Raeburn E. The Death of Cancer. New York: Sarah Crichton Books, 2015.

Ehrenreich B. Natural Causes: An Epidemic of Wellness, the Certainty of Dying, and Killing Ourselves to Live Longer. New York: Twelve, 2018.

Глава 1. Омар

Sullivan Th. A Tough Road: Cost to Develop One New Drug Is $ 2.6 Billion; Approval Rate for Drugs Entering Clinical Development Is Less Than 12 %. Policy and Medicine. www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html

DiMasi J. et al. Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs. Journal of Health Economics. 47 (2016): 20–33.

Wong C. H. et al. Estimation of Clinical Trial Success Rates and Related Parameters. Biostatistics. 20, no. 2 (2019): 273–286.

Kim Ch., Prasad V. Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival. JAMA Internal Medicine. 175, no. 12 (2015): 1992–1994.

Maeda H., Khatami M. Analyses of Repeated Failures in Cancer Therapy for Solid Tumors: Poor Tumor-Selective Drug Delivery, Low Therapeutic Efficacy and Unsustainable Costs. Clinical and Translational Medicine. 7, no. 1 (2018): 11.

Kumar H. et al. An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials. JAMA Oncology. 2, no. 9 (2016): 1238–1240.

Thomas D. W. et al. Clinical Development Success Rates, 2006–2015. www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006–2015 %20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

Philippidis A. Unlucky 13: Top Clinical Trial Failures in 2017. Genetic Engineering & Biotechnology News. www.genengnews.com/a-lists/unlucky-13-top-clinical-trial-failures-of-2017/

Szabo L. Dozens of New Cancer Drugs Do Little to Improve Survival, Frustrating Patients. https://khn.org/news/dozens-of-new-cancer-drugs-do-little-to-improve-survival-frustrating-patients/

Rupp T., Zuckerman D. Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints. JAMA Internal Medicine. 177, no. 2 (2017): 276–277.

Davis C. et al. Availability of Evidence on Overall Survival and Quality of Life Benefits of Cancer Drugs Approved by the European Medicines Agency: Retrospective Cohort Study of Drug Approvals from 2009–2013. BMJ. (2017): 359.

Hall S. S. A Commotion in the Blood: Life, Death, and the Immune System. New York: Henry Holt, 1997.

Sandomi R. Julie Yip-Williams, Writer of Candid Blog on Cancer, Dies at 42. New York Times, March 22, 2018. www.nytimes.com/2018/03/22/obituaries/julie-yip-williams-dies-writer-of-candid-blog-on-cancer.html